☀️     🌓

Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

Current Problems in Pharmacovigilance

The Medicines and Healthcare product Regulatory Agency (MHRA) has made the latest Current Problems in Pharmacovigilance available online. An index of recent issues dating back to 2001 is also available.

The latest issue details over 20 separate issues including:

  • Cancer risk with tacrolimus and pimecrolimus
  • HRT and risk of endometrial cancer
  • Jaw osteonecrosis with bisphosphonates
  • Optic neuropathy with linezolid

Action: Current Problems in Pharmacovigilance is a must read for all clinicians to raise awareness of new prescribing issues, interactions and potential adverse events brought to light through post-marketing surveillance.

Share 'Current Problems in Pharmacovigilance' by emailShare 'Current Problems in Pharmacovigilance' on FacebookShare 'Current Problems in Pharmacovigilance' on TwitterShare 'Current Problems in Pharmacovigilance' on MastodonShare 'Current Problems in Pharmacovigilance' on LinkedInShare 'Current Problems in Pharmacovigilance' on reddit

atomic-wealth

No Comments to “Current Problems in Pharmacovigilance”

Leave a Comment

Your email address will not be published. Required fields are marked *

Please be aware that you comment is subject to our Privacy Policy.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Prescribing Advice for GPs is powered by ClassicPress.
Connect to our RSS or Atom Feeds.